Infinity Pharmaceuticals, Inc. (INFI)
(Delayed Data from NSDQ)
$1.71 USD
+0.06 (3.64%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Infinity Pharmaceuticals, Inc. [INFI]
Reports for Purchase
Showing records 1 - 20 ( 169 total )
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
4Q21 Results; MARIO-4 Pivotal Study for Eganelisib in TNBC to Launch Before Year-End; MARIO-P Study Slated for 3Q22
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Pivotal Trial for Eganelisib in Frontline TNBC Set to Begin Before Year End; Reiterate Buy and Maintain $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
MARIO-3 Update Shows Eganelisib Maintained Impressive Efficacy and Safety in TNBC
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
SABCS Data Update on MARIO-3 Set for December 10; No New Data in Abstract Released Today
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Reports 3Q21 Results; SABCS Presentation Set for December 2021 is a Potential Major Catalyst
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Infinity Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department